AR096459A1 - Composiciones de corticosteroides y método de fabricación - Google Patents
Composiciones de corticosteroides y método de fabricaciónInfo
- Publication number
- AR096459A1 AR096459A1 ARP140102162A ARP140102162A AR096459A1 AR 096459 A1 AR096459 A1 AR 096459A1 AR P140102162 A ARP140102162 A AR P140102162A AR P140102162 A ARP140102162 A AR P140102162A AR 096459 A1 AR096459 A1 AR 096459A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacturing
- corticosteroid
- pharmaceutical composition
- corticosteroid compositions
- ester
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- -1 fatty acid ester Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 2
- 229960001102 betamethasone dipropionate Drugs 0.000 abstract 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 abstract 1
- 229960004703 clobetasol propionate Drugs 0.000 abstract 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 abstract 1
- 125000005908 glyceryl ester group Chemical group 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 229960001067 hydrocortisone acetate Drugs 0.000 abstract 1
- 229960002117 triamcinolone acetonide Drugs 0.000 abstract 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361830531P | 2013-06-03 | 2013-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR096459A1 true AR096459A1 (es) | 2015-12-30 |
Family
ID=51014660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102162A AR096459A1 (es) | 2013-06-03 | 2014-06-02 | Composiciones de corticosteroides y método de fabricación |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3003272A1 (https=) |
| JP (1) | JP2016520656A (https=) |
| CN (1) | CN105263474A (https=) |
| AR (1) | AR096459A1 (https=) |
| AU (1) | AU2014275195A1 (https=) |
| CA (1) | CA2912873A1 (https=) |
| HK (1) | HK1223300A1 (https=) |
| MX (1) | MX2015016603A (https=) |
| WO (1) | WO2014197398A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2637447T3 (es) | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Formulaciones tópicas que contienen un esteroide |
| US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| ITUB20153460A1 (it) * | 2015-09-08 | 2017-03-08 | Novamont Spa | Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico |
| BR112020010519A2 (pt) * | 2017-11-27 | 2020-10-20 | Umecrine Cognition Ab | formulação farmacêutica de oxima de 3¿lfa-etinil-3¿eta-hidroxiandrostan-17-ona |
| WO2023277616A1 (ko) * | 2021-06-30 | 2023-01-05 | 주식회사 디네이쳐 | 중대가리풀 유래의 추출물을 포함하는 탈모기능성 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1048820A (en) * | 1963-05-29 | 1966-11-23 | Merck & Co Inc | Emollient compositions containing liquid fatty acid esters |
| US4305936A (en) * | 1980-10-09 | 1981-12-15 | Dermik Laboratories | Topical corticosteroid formulations |
| US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
| US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
| JP3471840B2 (ja) * | 1993-03-04 | 2003-12-02 | 日本ワイスレダリー株式会社 | 外用剤 |
| US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
| GB9618964D0 (en) * | 1996-09-11 | 1996-10-23 | Tillotts Pharma Ag | Oral composition |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| MXPA01013460A (es) * | 1999-06-25 | 2003-09-04 | Durham Pharmaceuticals Ltd | Formulaciones topicas que comprenden agentes de penetracion de la piel y uso de las mismas. |
| JP2001233772A (ja) * | 2000-02-23 | 2001-08-28 | Taiho Yakuhin Kogyo Kk | 外用剤組成物 |
| KR100433614B1 (ko) * | 2000-06-16 | 2004-05-31 | 주식회사 태평양 | 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제 |
| PL1648412T3 (pl) * | 2003-07-07 | 2008-04-30 | Nares Ab | Mikroemulsje i ich zastosowanie do zapobiegania chorobom dróg oddechowych |
| EP1744760B1 (en) * | 2004-04-22 | 2015-01-07 | AcuCort AB | Pharmaceutical compositions for acute glucocorticoid therapy |
| CA2591296A1 (en) * | 2004-12-09 | 2006-06-15 | Bayer Healthcare Ag | Stabilisation of glucocorticoid esters with acids |
| US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
| FR2889662B1 (fr) * | 2005-08-11 | 2011-01-14 | Galderma Res & Dev | Emulsion de type huile-dans-eau pour application topique en dermatologie |
| FR2898498B1 (fr) * | 2006-03-15 | 2008-11-28 | Galderma Sa | Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant |
| GB2445539A (en) * | 2006-12-29 | 2008-07-16 | Ardana Bioscience Ltd | Bigel composition |
| US20090181068A1 (en) | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| AU2011264198B2 (en) * | 2010-06-11 | 2015-04-09 | Leo Pharma A/S | A pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
| WO2013076160A1 (en) * | 2011-11-21 | 2013-05-30 | Université Libre de Bruxelles | Sustained release formulations useful in the treatment of diseases |
| CN102940594A (zh) * | 2012-12-04 | 2013-02-27 | 艾能赛克机械设备(江苏)有限公司 | 一种头发调理剂 |
-
2014
- 2014-06-02 AR ARP140102162A patent/AR096459A1/es unknown
- 2014-06-02 CN CN201480031734.4A patent/CN105263474A/zh active Pending
- 2014-06-02 CA CA2912873A patent/CA2912873A1/en not_active Abandoned
- 2014-06-02 WO PCT/US2014/040560 patent/WO2014197398A1/en not_active Ceased
- 2014-06-02 HK HK16111676.0A patent/HK1223300A1/zh unknown
- 2014-06-02 MX MX2015016603A patent/MX2015016603A/es unknown
- 2014-06-02 JP JP2016518385A patent/JP2016520656A/ja active Pending
- 2014-06-02 AU AU2014275195A patent/AU2014275195A1/en not_active Abandoned
- 2014-06-02 EP EP14733041.9A patent/EP3003272A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MX2015016603A (es) | 2016-07-28 |
| JP2016520656A (ja) | 2016-07-14 |
| WO2014197398A1 (en) | 2014-12-11 |
| AU2014275195A1 (en) | 2015-12-10 |
| EP3003272A1 (en) | 2016-04-13 |
| HK1223300A1 (zh) | 2017-07-28 |
| CN105263474A (zh) | 2016-01-20 |
| CA2912873A1 (en) | 2014-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR096459A1 (es) | Composiciones de corticosteroides y método de fabricación | |
| BR112015023629A8 (pt) | Formulação de acetato de abiraterona | |
| CL2019001447A1 (es) | Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos. | |
| EA201590730A1 (ru) | Способ и стероидная композиция для местного применения | |
| CO2017003396A2 (es) | Esteroides neuroactivos, composiciones y usos de los mismos | |
| AR102198A1 (es) | Proceso para reducir partículas subvisibles en una formulación farmacéutica | |
| EP3260463A4 (en) | Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof | |
| MX2018010902A (es) | Esteroides neuroactivos, composiciones y usos de los mismos. | |
| DOP2015000202A (es) | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno | |
| CA2929865C (en) | Sprayable topical carrier and composition comprising phosphatidylcholine | |
| UY34617A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas | |
| AR108073A1 (es) | Composición farmacéutica de hormona esteroide, método | |
| UA114615C2 (uk) | Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти | |
| CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
| EP3454840A4 (en) | COMPOSED FORMULATION OF DUTASTERIDE AND TADALAFIL WITH GLYCERINE Fatty Acid Ester Derivative Or Propylene Glycol Fatty Acid Ester Derivative And Oral Capsule Formulation With It | |
| EA201691808A8 (ru) | Кортикостероидные композиции для местного применения | |
| MX2016000964A (es) | Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. | |
| CL2016002560A1 (es) | Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación. | |
| ECSP15022442A (es) | Producto de comicronización que comprende acetato de ulipristal | |
| PT3768241T (pt) | Composição tópica compreendendo calcipotriol e dipropionato de betametasona | |
| CO2017004382A2 (es) | Composiciones farmacéuticas que comprenden lobeglitazona para administración oral | |
| UY36948A (es) | Formulaciones de corticosteroides para mantener concentraciones de corticosteroide en el líquido sinovial | |
| MX2019013049A (es) | Composicion para el cuidado del cabello que comprende compuestos de tri-esteres y esteres grasos de acido benzoico. | |
| JP2015034162A5 (https=) | ||
| WO2017058739A3 (en) | Cooling formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |